William Weber

All articles by William Weber

Company Receives Approval for Anchored Catheter

Interrad Medical, Inc., of Plymouth, Minn., has received clearance of its SecurAcath peripherally inserted central catheter (PICC) with Subcutaneous Securement System, which deploys a small anchor in the subcutaneous tissue just beneath the skin to hold an indwelling catheter securely in place.

Alpha Blocker Approved for BPH Treatment

Rapaflo (silodosin), an alpha blocker marketed by Watson Pharmaceuticals, Inc., in Corona, Calif., for oral, once-daily treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) has received approval.

Prognostic Claim with Resubmission of PSA Test Application

IRIS International, Inc., of Chatsworth, Calif., after extensive consultation with the FDA, plans to resubmit its 510(k) application for the company’s NADiA PSA ultrasensitive diagnostic test with a prognostic claim for identifying post-prostatectomy patients at low risk of prostate cancer recurrence.

Next post in FDA News